Blinding Integrity
Blinding Integrity is a methodological safeguard within protocol compliance that ensures the maintenance of concealed treatment allocation throughout a study, thereby preventing performance and detection biases by preserving the separation between intervention assignment and assessment.
47
Publications
4.2K
Citations
207
Authors
117
Institutions
Publications per year
2017–2026
15
Parents
47
Assessment of blinding in clinical trials
Heejung Bang, Liyun Ni, C.E. Davis · Controlled Clinical Trials · 2004 · 665 citations
1–5 of 47
207
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 207
117

Centers for Disease Control and Prevention
Atlanta, United States
3 h-index
3 publications
79 citations
Charité - Universitätsmedizin Berlin
Berlin, Germany
3 h-index
11 publications
427 citations
University of Oxford
Oxford, United Kingdom
3 h-index
4 publications
121 citations

Imperial College London
London, United Kingdom
2 h-index
4 publications
165 citations
Rigshospitalet
Copenhagen, Denmark
2 h-index
4 publications
230 citations

McMaster University
Hamilton, Canada
2 h-index
5 publications
622 citations
Yale University
New Haven, United States
2 h-index
2 publications
62 citations

University of South Australia
Adelaide, Australia
2 h-index
6 publications
370 citations
1–8 of 117
3 publications · 509 citations
3
h-index
3 publications · 390 citations
3
h-index
2 publications · 73 citations
2
h-index
2 publications · 68 citations
2
h-index
2 publications · 58 citations
2
h-index
1–5